Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Larry Robbins Boosts Stake in $URS Corp

Larry Robbins filed a 13G on Monday disclosing a 3.9 million share position in URS Corp (URS). Glenview Capital had 3.55 million shares of URS at the end of December. The stock is up 13% so far this year. Larry Robbins is really the only hedge fund manager who is very bullish about this stock. D.E. Shaw and AQR Capital had $41 million and $31 million invested in URS.


According to Yahoo Finance, URS Corporation provides engineering, construction, and technical services to public agencies and private sector clients worldwide. The company plans, designs, engineers, constructs, retrofits, and maintains a range of power-generating facilities; and systems that transmit and distribute electricity, as well as develops and installs clean air technologies. It also offers services to build, expand, and modernize infrastructure, such as surface, air, and rail transportation networks; ports and harbors; and water supply, treatment, and conveyance systems, as well as provides operations and maintenance services for completed projects. In addition, the company offers program management; planning, design, and engineering; systems engineering and technical assistance; and IT services to construction and construction management, as well as operations and maintenance, and decommissioning and closure services to various government departments and agencies.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!